Copyright medicaldialogues
New Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has fixed retail prices for 28 essential drug formulations including a wide range of combination drugs commonly prescribed for diabetes, hypertension, allergies, infections, and gastrointestinal conditions.The prices, determined under the Drugs (Prices Control) Order, 2013 (DPCO), are exclusive of Goods and Services Tax (GST) and apply to specific manufacturers and marketing companies that applied under Form-I for price fixation.The formulations include combinations such as Amlodipine with Valsartan, Dapagliflozin with Sitagliptin and Metformin, Empagliflozin with Linagliptin or Sitagliptin and Metformin, Telmisartan-based triple combinations, Levocetirizine with Montelukast, and Amoxycillin with Clavulanate, among others.Also Read: Knee Implant Prices Under Fresh Review: NPPA Weighs 10% Hike Request from ManufacturersSome of the notable price approvals include Windlas Biotech / Alembic Pharmaceuticals' Amlodipine and Valsartan Tablets, Exemed Pharmaceuticals/ Corona Remedies' Empagliflozin, Linagliptin and Metformin Hydrochloride Extended Release Tablets, Ravenbhel Healthcare/Cipla's Levocetirizine Hydrochloride and Montelukast Syrup, Ajanta Pharma/ Sun Pharma Laboratories' Metoprolol succinate Extended Release, Amlodipine and Telmisartan Tablets, Pure and Cure Healthcare/ Dr. Reddy’s Laboratories' Mefenamic acid and Paracetamol Tablets, and others.This came in exercise of the powers conferred by paragraphs 5, 11, and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (NPPA) has fixed, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer and marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;Sl.No.MedicineStrengthUnitManufacturer & Marketing CompanyRetail Price (Rs.)(1)(2)(3)(4)(5)(6)1Amlodipine & Valsartan TabletsEach film coated tablet contains: Amlodipine besylate IP eq. to Amlodipine 5 mgValsartan IP 80 mg1 TabletM/s Windlas Biotech Ltd./ M/s Alembic Pharmaceuticals Ltd.7.412Dapagliflozin, Sitagliptin & Metformin Hydrochloride (Extended Release) TabletsEach film coated bilayered tablet contains:Dapagliflozin Propanediol USP Eq. to Dapagliflozin 10 mgSitagliptin Phosphate Monohydrate IP Eq. to Sitagliptin 100 mg Metformin Hydrochloride IP 500 mg (As extended release form)1 TabletM/s Windlas Biotech Ltd. / M/s Jagsonpal Pharmaceuticals Ltd.18.183Empagliflozin, Linagliptin & Metformin Hydrochloride Extended Release TabletsEach film coated bilayer tablet contains:Empagliflozin 10mg Linagliptin 5 mg Metformin Hydrochloride(Extended Release) IP 1000 mg1 TabletM/s Exemed Pharmaceuticals/M/s Corona Remedies Pvt. Ltd.29.214Empagliflozin, Sitagliptin and Metformin Hydrochloride Extended Release TabletsEach film coated bilayer tablet contains:Empagliflozin 25 mgSitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 100 mg, Metformin Hydrochloride (As Extended Release) IP 1000 mg1 TabletM/s Exemed Pharmaceuticals/ M/s Alembic Pharmaceuticals Ltd.25.005Levocetirizine Hydrochloride & Montelukast SyrupEach 5 ml contains:Levocetirizine Hydrochloride IP 2.5 mgMontelukast Sodium IP eq. to Montelukast 5 mg1 mlM/s Ravenbhel Healthcare Pvt. Ltd.M/s Cipla Ltd.1.886Linagliptin & Metformin Hydrochloride (ER) TabletsEach film coated bilayered tablet contains:Linagliptin 5 mgMetformin Hydrochloride IP 500 mg(As extended-release form)1 TabletM/s Mascot Health Series Pvt. Ltd./M/s Primus Remedies Pvt. Ltd.10.097Metoprolol succinate Extended Release, Amlodipine & Telmisartan TabletsEach film coated bilayered tablet contains:Metoprolol succinate IP 23.75 mg eq. to Metoprolol Tartrate 25 mg (As extended release) Amlodipine Besilate IP eq to Amlodipine 5 mgTelmisartan IP 40 mg1 TabletM/s Ajanta Pharma Ltd./ M/s Sun Pharma Laboratories Ltd.13.018Mefenamic acid & Paracetamol TabletsEach uncoated tablet contains: Mefenamic Acid IP 500 mg Paracetamol IP 325 mg1 TabletM/s Pure & Cure Healthcare Pvt. Ltd./M/s Dr. Reddy’sLaboratories Ltd.3.919S (-) Pantoprazole for Injection (Lyophilized)Each vial contains:S (-) Pantoprazole Sodium equivalent to S (-) Pantoprazole 20mg1 VialM/s Gufic Biosciences Ltd.118.39Sl.No.MedicineStrengthUnitManufacturer & Marketing CompanyRetail Price (Rs.)10S (-) Pantoprazole for Injection (Lyophilized)Each vial contains:S (-) Pantoprazole Sodium equivalent to S (-) Pantoprazole 20mg1 VialM/s Gufic Biosciences Ltd./ M/s Tyykem Pvt. Ltd.118.3911Paracetamol &...
